CENTENE CORP - 8-K Filing

Centene reaffirms full year 2026 GAAP diluted EPS guidance of >$3.11 and adjusted diluted EPS guidance of >$4.80 ahead of Deutsche Bank Healthcare Summit. (Items: 7.01 REGULATION FD DISCLOSURECentene Corporation (the Company) will be participating at the Deutsche Bank 2026 Healthcare Summit on Wednesday, Sep)

SEC EDGAR · September 16, 2026, 11:53 UTC

Tickers: $CNC

Read the full article at SEC EDGAR

More Regulatory news

SAGA COMMUNICATIONS INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:05 UTC
NextBoat Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:05 UTC
CIVISTA BANCSHARES, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 14:05 UTC
RF Acquisition Corp II - 10-Q Filing SEC EDGAR · November 12, 2026, 14:04 UTC
ORASURE TECHNOLOGIES INC - 10-Q Filing SEC EDGAR · November 12, 2026, 14:03 UTC
Rocket Companies, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:03 UTC
Applied Aerospace & Defense, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:02 UTC
Palomar Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:02 UTC
UNITED GUARDIAN INC - 10-Q Filing SEC EDGAR · November 12, 2026, 14:00 UTC
Dare Bioscience, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:00 UTC